#glp-1-drugs-addiction-treatment

[ follow ]
#weight-loss #glp-1-drugs #glp-1-medications #glp-1 #obesity-treatment #fda-approval #semaglutide #eli-lilly #wegovy
#glp-1
SF food
fromwww.npr.org
1 week ago

What does a 'GLP-1 Friendly' diet look like? We asked nutritionists

Food companies are branding products as 'GLP-1 Friendly' to cater to consumers using obesity and diabetes medications.
Medicine
fromwww.businessinsider.com
1 day ago

A new weight-loss pill is here. Here's how Foundayo compares to Wegovy, Zepbound, and other GLP-1 rivals.

Eli Lilly's Foundayo, a new weight loss pill, offers flexible dosing and outperforms competitors in weight loss and health metrics.
Medicine
from24/7 Wall St.
3 days ago

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

The GLP-1 revolution is driving biopharma M&A strategies, with companies like Viking Therapeutics and Structure Therapeutics as prime acquisition targets.
Medicine
fromSlate Magazine
1 week ago

The Risk Too Many People Are Taking With Ozempic

GLP-1 receptor agonists, while effective for obesity and diabetes, may cause significant gastrointestinal issues and other health risks.
more#glp-1
#obesity-treatment
more#obesity-treatment
#wegovy
NYC startup
fromFast Company
3 days ago

Wegovy's new pricing could save you $1,200-but it's not for everyone

Novo Nordisk launched a subscription program for Wegovy to reduce cost uncertainty and improve access to obesity treatment.
Medicine
fromwww.bbc.com
3 days ago

Weight-loss jabs will be offered on NHS for people at risk of further heart attacks

Wegovy will be provided for free on the NHS to over a million at-risk individuals in England to reduce heart attack and stroke risks.
NYC startup
fromFast Company
3 days ago

Wegovy's new pricing could save you $1,200-but it's not for everyone

Novo Nordisk launched a subscription program for Wegovy to reduce cost uncertainty and improve access to obesity treatment.
Medicine
fromwww.bbc.com
3 days ago

Weight-loss jabs will be offered on NHS for people at risk of further heart attacks

Wegovy will be provided for free on the NHS to over a million at-risk individuals in England to reduce heart attack and stroke risks.
more#wegovy
Wellness
fromAxios
1 week ago

What the GLP-1 era means for body positivity

Media trends are reverting to ultra-thinness, undermining body positivity efforts and creating societal divides in body image perception.
#weight-loss
Psychology
fromPsychology Today
1 week ago

What Weight-Loss Drugs Reveal About How We Judge Effort

Visible struggle in weight loss is often misinterpreted as greater effort, while underlying biological and psychological factors play a significant role.
Psychology
fromPsychology Today
1 week ago

What Weight-Loss Drugs Reveal About How We Judge Effort

Visible struggle in weight loss is often misinterpreted as greater effort, while underlying biological and psychological factors play a significant role.
Medicine
fromwww.theguardian.com
2 days ago

US approves new oral weight-loss pill developed by Eli Lilly

FDA approved orforglipron, a new oral weight-loss medication by Eli Lilly, offering an alternative to injectable GLP-1 treatments.
Medicine
fromABC7 New York
2 days ago

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.
more#weight-loss
Healthcare
fromTechCrunch
1 week ago

Riding the GLP-1 boom, VITL lands $7.5M to overhaul cash-pay clinic prescribing | TechCrunch

VITL provides an e-prescribing platform tailored for cash-pay medical businesses, significantly improving prescription management efficiency for clinics.
#fda-approval
Medicine
fromwww.scientificamerican.com
1 day ago

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

Eli Lilly's orforglipron received FDA approval as a weight loss treatment, showing significant weight loss in clinical trials.
Medicine
fromwww.scientificamerican.com
1 day ago

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

Eli Lilly's orforglipron received FDA approval as a weight loss treatment, showing significant weight loss in clinical trials.
more#fda-approval
#glp-1-drugs
fromBusiness Insider
1 month ago
Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

fromFuturism
1 week ago
Medicine

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

fromBusiness Insider
1 month ago
Healthcare

Eli Lilly is set to release a once-daily pill to rival Ozempic this year. People are losing 15 to 20 pounds on it, but there's a catch.

Medicine
fromFuturism
1 week ago

Scientists Just Found Something Rather Grim That Happens When You Stop Taking GLP-1s

Stopping GLP-1 drugs can quickly reverse health benefits, increasing cardiovascular risks and leading to weight regain and other health issues.
Medicine
fromwww.scientificamerican.com
2 weeks ago

The GLP-1 saga is only getting juicier and messier

The FDA warned Novo Nordisk about failing to disclose risks and report deaths linked to semaglutide, while GLP-1 drugs surge in popularity for diabetes and weight loss despite unapproved market alternatives.
more#glp-1-drugs
#obesity
Medicine
fromWIRED
2 days ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
Medicine
fromWIRED
2 days ago

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.
more#obesity
#glp-1-medications
Medicine
fromScienceDaily
2 weeks ago

What happens after Ozempic shocked researchers

Stopping GLP-1 medications like Ozempic does not typically lead to significant weight regain, as many patients switch treatments or restart therapy.
Public health
fromInsideHook
2 months ago

Research Suggests GLP-1 Drugs Could Be for the Long Haul

People using GLP-1 weight-loss medications often require long-term or lifelong treatment because stopping them commonly leads to rapid weight regain and lost metabolic benefits.
Wellness
fromPsychology Today
1 month ago

GLP-1s and the Thin Ideal

GLP-1 medications in a culture equating thinness with worth risk reinforcing body surveillance, masking eating disorders, and creating harmful weight cycling patterns with psychological consequences.
Medicine
fromScienceDaily
2 weeks ago

What happens after Ozempic shocked researchers

Stopping GLP-1 medications like Ozempic does not typically lead to significant weight regain, as many patients switch treatments or restart therapy.
more#glp-1-medications
Medicine
fromwww.theguardian.com
3 days ago

NHS England to offer weight-loss drugs to 1.2m people to reduce risk of heart attacks and strokes

NHS England will provide weight-loss drugs to over 1 million people to reduce heart attack and stroke risks.
Medicine
fromwww.scientificamerican.com
2 weeks ago

Experimental GLP-3 weight loss drug retatrutide shows promising results in clinical trial

Retatrutide, a triple-receptor GLP-3 agonist drug, achieved up to 36.6 pounds of average weight loss and improved blood sugar control in phase 3 clinical trials for type 2 diabetes.
#glp-1-receptor-agonists
Medicine
fromwww.theguardian.com
2 weeks ago

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.
Medicine
fromNature
2 weeks ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.
Medicine
fromwww.theguardian.com
2 weeks ago

GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

GLP-1 receptor agonists, particularly semaglutide and liraglutide, reduce the risk of worsening anxiety and depression in people with diabetes.
Medicine
fromNature
2 weeks ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.
more#glp-1-receptor-agonists
#glp-1-agonists
Medicine
fromwww.theguardian.com
2 weeks ago

The Guardian view on weight-loss jabs and addiction: there is too much moralising about these remarkable medicines | Editorial

Weight-loss drugs show promise in reducing addiction risk, suggesting they may address shared biological mechanisms between food and drug cravings in the brain.
Medicine
fromwww.theguardian.com
2 weeks ago

The Guardian view on weight-loss jabs and addiction: there is too much moralising about these remarkable medicines | Editorial

Weight-loss drugs show promise in reducing addiction risk, suggesting they may address shared biological mechanisms between food and drug cravings in the brain.
more#glp-1-agonists
Marketing
fromDigiday
1 month ago

GLP-1 draws pharma advertisers to double down on the Super Bowl

Pharmaceutical and healthcare brands are heavily advertising GLP-1 and related products during the Super Bowl despite potential regulatory threats to pharma advertising.
Public health
fromBBC
1 month ago

Inside Health - What are the side effects of weight loss drugs? - BBC Sounds

Weight loss drugs were used by over 1.5 million UK adults in 2024–25 and can cause side effects including nausea and painful gallstones.
Healthcare
fromThe Atlantic
1 month ago

GLP-1 Envy Was Just the Beginning

Telehealth companies market paid services that promise wealthy-style, personalized concierge care, highlighting and monetizing the divide between elite proactive care and reactive mainstream care.
Medicine
fromwww.scientificamerican.com
2 weeks ago

Drugs like Ozempic are improving kidney treatment and changing lives

GLP-1 receptor agonists, finerenone, and SGLT2 inhibitors represent breakthrough treatments for chronic kidney disease, with combined therapy potentially adding decades to patients' lives.
Public health
fromwww.bbc.com
2 months ago

Could weight-loss jabs be behind rising gallbladder removals?

Specialist doctors call for more research into a possible link between GLP-1 weight-loss injections and rising gallbladder removals and gallstones.
fromwww.theguardian.com
4 weeks ago

Weight-loss jab could be made for $3 a month, study finds

New research, published as a pre-print, suggests that semaglutide could be mass produced for $3 (about 2.35) for a monthly dose in its injectable form. Newer formulations, taken as a pill rather than an injection, could be made for about $16 a month.
Medicine
fromFast Company
2 months ago

Wegovy pill: Where to find Novo Nordisk's new GLP-1 for weight loss-and how much it costs

The Wegovy pill-which has been in clinical trials for over two years and was approved by the FDA on December 22-is the first and only oral GLP-1 for weight loss in adults available in the U.S. According to a press release from Novo Nordisk, the pill hit the market on January 5 at more than 70,000 U.S. pharmacies and several popular telehealth providers. Per a KFF health tracking poll released in November, one in eight Americans were already taking a GLP-1 for weight-loss.
Medicine
fromScienceDaily
2 months ago

An endocrinologist tried a new weight loss approach and it worked

A Colorado endocrinologist helped spark a quiet revolution in weight care by changing how primary care clinics talk about - and treat - obesity. Instead of vague advice to "eat less and exercise more," a new system called PATHWEIGH gave patients a clear, judgment-free path to real medical support for weight management.
Medicine
[ Load more ]